Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis.

Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis.

BACKGROUND: This study aims to comprehensively summarize the currently available evidences on the efficacy and safety of gemcitabine plus erlotinib for treating advanced pancreatic cancer. METHODOLOGY/PRINCIPAL FINDINGS: PubMed, EMBASE, The Cochrane Library and abstracts of recent major conferences...

Full description

Bibliographic Details
Main Authors: Zu-Yao Yang, Jin-Qiu Yuan, Meng-Yang Di, Da-Yong Zheng, Jin-Zhang Chen, Hong Ding, Xin-Yin Wu, Ya-Fang Huang, Chen Mao, Jin-Ling Tang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3589410?pdf=render

Internet

http://europepmc.org/articles/PMC3589410?pdf=render

Similar Items